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Abstract 
Photodynamic therapy (PDT) is an alternative treatment for cancer that involves 
administration of a photosensitive drug or photosensitizer that localizes at the tumor tissue 
followed by in situ excitation at an appropriate wavelength of light. Tumour tissues are then 
killed by cytotoxic reactive oxygen species generated by the photosensitizer. Targeted 
excitation and photokilling of affected tissues is achieved through focal light irradiation, 
thereby minimizing systemic side effects to the normal healthy tissues. Currently, there are 
only a small number of photosensitizers that are in the clinic and many of these share the 
same structural core based on cyclic tetrapyrroles. This paper describes how metabolic tools 
are utilized to prioritize natural extracts to search for structurally new photosensitizers from 
Malaysian biodiversity. As proof of concept, we analyzed 278 photocytotoxic extracts using a 
hyphenated technique of liquid chromatography–mass spectrometry coupled with principal 
component analysis (LC–MS-PCA) and prioritized 27 extracts that potentially contained new 
photosensitizers for chemical dereplication using an in-house UPLC-PDA-MS-
Photocytotoxic assay platform. This led to the identification of 2 new photosensitizers with 
cyclic tetrapyrrolic structures, thereby demonstrating the feasibility of the metabolic approach. 
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